N
NovaCardia
Acquired- Business Model
- B2B
- Acquisition Date
- Sep 2007
Indexed holds 1 funding round for this company. The full record is or through the API.
About
Cardiovascular drug development
Summary
NovaCardia is a Biotech company.
Exit History
Sep 2007
Similar Companies
AsymchemIPO
Asymchem is a pharmaceutical CDMO providing R&D, chemistry, manufacturing, and control services t...
Tianjin, China5001–10000Biotech, Drug Discovery
Private EquityTotal funding$2.3BFeb 2020
Abogen Biosciences
Abogen Biosciences develops RNA therapeutics using integrated mRNA design, lipid nanoparticle del...
Suzhou, China201–500Biotech, Drug Discovery
Extension RoundTotal funding$1.2BNov 2021
Enveda
Enveda reads and translates nature’s hidden chemistry to accelerate the discovery of better medic...
Boulder, United States201–500Biotech, Artificial Intelligence
Series ETotal funding$1.1BSep 2026
Eikon TherapeuticsIPO
Late-stage biopharma using single-molecule tracking, AI, and engineering to discover and develop ...
Hayward, United States201–500Artificial Intelligence, Biotech
Series DTotal funding$1.1BFeb 2025
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/novacardia"><img src="https://indexed.vc/api/badge/company/novacardia" alt="NovaCardia on Indexed.vc" width="260" height="76" /></a>